Quetiapine: focus on emotional numbing in depersonalization disorder: an fMRI case report

European Psychiatry

Volumn 21, Issue 8, 2006, Pages 574-577

  Mancini Marïe, Adham ^a,b   Fahim, Cherine ^a,b   Potvin, Stéphane ^a,b   Beauregard, Mario ^b,c   Stip, Emmanuel ^a,b  

^a CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c CENTRE DE RECHERCHE   (Canada)

Author keywords

Depersonalization; Emotional numbing; Functional magnetic resonance imaging; Quetiapine

Indexed keywords

CITALOPRAM; LORAZEPAM; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEPERSONALIZATION; DISEASE COURSE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EMOTIONAL DISORDER; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MALE; NEUROIMAGING; PANIC; PRIORITY JOURNAL; SELF REPORT; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; BRAIN; BRAIN MAPPING; DEPERSONALIZATION; DIBENZOTHIAZEPINES; EMOTIONS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PANIC DISORDER; SELF DISCLOSURE; TREATMENT OUTCOME;

EID: 33845292254     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2005.05.014     Document Type: Article

References (10)

1. Bernstein E.M., and Putnam F.W. Development, reliability, and validity of a dissociation scale. J. Nerv. Ment. Dis. 174 (1986) 727-735
2. Cheer S.M., and Wagstaff A.J. Quetiapine: a review of its use in the management of schizophrenia. CNS Drugs 18 (2004) 173-199
3. Gurley R.J., Aranow R., and Katz M. Medicinal marijuana: a comprehensive review. J. Psychoactive Drugs 30 (1998) 137-147
4. Morris J.S., Ohman A., and Dolan R.J. A subcortical pathway to the right amygdala mediating "unseen" fear. Proc. Natl. Acad. Sci. USA 96 (1999) 1680-1685
5. Phan K.L., Wager T., Taylor S.F., and Liberzon I. Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI. Neuroimage 16 (2002) 331-348
6. Phillips M.L., Medford N., Senior C., Bullmore E.T., Suckling J., Brammer M.J., et al. Depersonalization disorder: thinking without feeling. Psychiatry Res. 108 (2001) 145-160
7. Philips M.L., and Sierra M. Depersonalization disorder: a functional neuroanatomical perspective. Stress 6 (2003) 157-165
8. Sierra M., and Berrios G.E. Depersonalization: neurobiological perspectives. Biol. Psychiatry 44 (1998) 898-908
9. Sierra M., and Berrios G.E. The Cambridge Depersonalization Scale: a new instrument for the measurment of depersonalization. Psychiatry Res. 93 (2000) 153-164
10. Stip E., Fahim C., Mancini-Marië A., Bentaleb L.A., Mensour B., Mendrek A., et al. Restoration of frontal activation during a treatment with quetiapine: an fMRI study of blunted affect in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 29 (2005) 21-26